Introduction
Medulloblastoma are tumors of the cerebellum that most commonly occur within the first few years of life. Children with the disease face a 3-year event-free survival rate of less than 35% if the tumor is metastatic or recurrent or if the child is o3 years old (Packer, 1994) . The approach of clinical trial cooperative groups toward these patients has been the intensification of post-surgical chemotherapeutic and brain radiation regimens, but recent advances have been limited. Even when successful, current therapies cause major toxicities, including severe cognitive impairment, endocrine deficiencies, renal failure, hearing loss and psychiatric and social difficulties. The elucidation of signaling pathways involved in medulloblastoma pathogenesis could substantially improve the clinical management of these neoplasms, a more accurate prediction of the disease risk could be achieved and new targeted treatments developed.
A number of studies have identified candidatesignaling pathways, which may have a role in the genesis of medulloblastoma (Marino, 2005) . The potential complexity of the interaction of signaling pathways that give rise to medulloblastoma is reflected in the diversity of knockout and transgenic mouse models that have been found to develop medulloblastoma. These include cell cycle regulators such as Ink4c (Zindy et al., 2007) , p53/Rb (Marino et al., 2000; Wetmore et al., 2001) , Bmi1 (Leung et al., 2004) , Ren KCTD11 (Di Marcotullio et al., 2004) , Brca2 (Frappart et al., 2007) and Parp (Tanori et al., 2008) , chemokine receptor Cxcr6 (Sasai et al., 2007) , growth factors Hgf (Binning et al., 2008) , Igf1 (Rao et al., 2004) and Ifna (Wang et al., 2003) , a regulator of PKA activity, Pacap (Lelievre et al., 2008) , and the transcription factor Hic1 (Briggs et al., 2008) . In the mouse at least most of these manipulations appear to either directly modulate the Hedgehog-signaling pathway or cooperate with it to generate the medulloblastoma.
Insight into the molecular basis of medulloblastoma has come from studies of the Hedgehog-signaling pathway. Sonic hedgehog (Shh) is a secreted protein that has a critical role in patterning of the nervous system, the limbs, the skin and other tissues (Wicking et al., 1999) . Patched1 (Ptc1) is a transmembrane protein that can bind Shh and appears to serve as a receptor. The first evidence that Hedgehog signaling might be involved in medulloblastoma came from studies of the human PATCHED (PTCH1) gene in an inherited cancer disposition syndrome, Naevoid Basal Cell Carcinoma Syndrome (NBCCS), which is characterized by widespread skin tumors, craniofacial and skeletal abnormalities, and an increased incidence of medulloblastoma. PTCH1 was found to be mutated in both the inherited and sporadic form of basal cell carcinoma (Hahn et al., 1996) and subsequently it was discovered that in some studies up to 20% of sporadic medulloblastoma have causative mutations at the PTCH1 locus (Pietsch et al., 1997; Vorechovsky et al., 1997; Dong et al., 2000) . Mutation of the Hedgehog pathway mediator suppressor of fused has also been observed in medulloblastoma and provides a potential mechanistic link between Hedgehog signaling and the Wnt signaling pathway in this tumor . Although mutation of Hedgehog pathway components is present in a minority of medulloblastoma (approximately 25%), the pathway is detected as perturbed by unknown mechanisms in most tumors (Hallahan et al., 2004; Thompson et al., 2006) . Small molecule inhibitors of the Hedgehog pathway show significant activity in Ptc1 medulloblastoma animal models and on that basis are currently in clinical trials (Romer and Curran, 2005; Rudin et al., 2009) .
The Notch receptor-signaling pathway has a key role in many different cell fate decisions and has a particular prominence due to its function as a key determinant of asymmetric/symmetric cell division (Corbin et al., 2008) . Notch signaling uses a membrane bound ligand that contacts an appropriate receptor leading to the release of a cytoplasmic fragment of the receptor, which then binds to a multi-unit complex capable of transcriptional regulation, transforming it from a repressor to an activator complex. In mammals, ligands include members of the Delta-like (Dll1, Dll3, Dll4) and Jagged (Jag1, Jag2) families, and receptors include Notch1-4. Given the array of Notch ligands and receptors it is not surprising that this pathway forms a complex network, which interacts with many other pathways such as Hedgehog, Wnt/wingless and TGFb (Hurlbut et al., 2007) . The Notch pathway likely has a significant role in the genesis of medulloblastoma and it clearly has a role in normal cerebellar development (Tanaka et al., 1999; Klein et al., 2004; Komine et al., 2007; Koo et al., 2007) . Perturbation of Notch1 receptor signaling negatively regulates growth of the external germinal layer (EGL) whereas activation of Notch2 receptor promotes granule cell proliferation (Solecki et al., 2001) . Other ligands, receptors and targets (Jag1, Jag2, Dll1, Dll3, Notch3, Notch4, Hes1, Hes5) are also expressed in the developing cerebellum (Stump et al., 2002; Gazit et al., 2004; Irvin et al., 2004; Weller et al., 2006) . A number of studies have noted dysregulation of Notch pathway components in both human and murine medulloblastoma (Berman et al., 2002; Hallahan et al., 2004; Yokota et al., 2004; Dakubo et al., 2006) including the transcription factor targets Hes1 and Hes5, and the expression of Hes1 is associated with poor clinical outcome (Fan et al., 2004) . Medulloblastoma cell lines treated with g-secretase inhibitors that block Notch receptor endoproteolysis display reduced growth, clonogenicity and tumorigenicity (Hallahan et al., 2004; Fan et al., 2006) . Accordingly, g-secretase inhibitors have been proposed as a chemotherapeutic approach to treating medulloblastoma (Purow, 2009) .
Although it has been suggested that removing Notch function in medulloblastoma may be a powerful therapeutic approach, particularly in those in which the Hedgehog pathway is activated (Hallahan et al., 2004) , in vivo evidence supporting this strategy has yet to be described. The Ptc1 mutant mouse is a widely accepted and relevant model for human medulloblastoma (Pazzaglia et al., 2006; Yang et al., 2008; Thomas et al., 2009) , and here we addressed the intersection of Hedgehog and Notch signaling in vivo using a genetic approach to ablate Notch signaling in this model. The developing cerebellum expresses multiple components of the Notch-signaling pathway, including at least 4 ligands, 4 receptors and multiple putative downstream effectors, and the rhombic lip/ EGL itself expresses receptors Notch1, Notch2, Notch4 and ligands Jag1, Dll1, at least. Although the combinatorial complexity of Notch ligand/receptor is high, all 'canonical' Notch signaling requires the CSL/Rbpj (RBP-J) transcription co-factor so in practice, inhibition of RBP-J function will negate Notch receptor signaling (Komine et al., 2007) . There is some emerging genetic evidence to suggest the existence of an RBP-J-independent ('non-canonical') pathway through which Notch receptor signaling may exert some influence (Talora et al., 2008) . However, the key effectors implicated in medulloblastoma growth, Hes1 and Hes5 are clearly both 'canonical' Notch targets (Jarriault et al., 1995 (Jarriault et al., , 1998 Sweeney et al., 2004; Ong et al., 2006) . Given the number of ligands and receptors potentially having a role in the cerebellum, here we took the approach of blocking Notch signaling by deleting the common pathway effector RBP-J, which has proved to be a highly effective strategy in analyses of Notch signaling (Fujikura et al., 2006; Komine et al., 2007) . Our results indicate that although loss of RBP-J function results in a developmental delay both within the stem cell niche and consequently in granule neuron precursor development, this leaves cerebellar development largely intact and these effects can be moderated by Hedgehog pathway activation. Medulloblastoma formed at high frequency following Hedgehog pathway activation and loss of Notch signaling failed to prevent either expansion of granule neuron precursors (GNPs) or the subsequent development of medulloblastoma.
Results
The RBP-J gene is efficiently inactivated in the external germinal layer of RBP-J lox/lox ;GFAP-Cre mice Through a combination of expression analyses and lineage tracing, the function of the GFAP-Cre allele used in this study has been previously defined at key stages of cerebellar development from E12.5 (Yang et al., 2008) . GFAP-Cre directed recombinase function is found in the ventricular zone (VZ) and cells derived from that layer with the exception of Purkinje neurons, which appear to originate from a GFAP-negative population of VZ cells. In addition, the GFAP-Cre allele directs a high level (495%) of excision of a conditional Ptc1 allele leading to activation of the Hedgehog pathway, expansion of granule neuron precursors and to medulloblastoma that are fully penetrant by p21 (Yang et al., 2008; Figure 5) . As the approach taken here depends upon a high level of excision of a conditional RBP-J allele concomitant with the Ptc1 allele, we examined the level of RBP-J deletion in cells derived from the VZ of RBP-J lox/lox ;GFAP-Cre mice and controls at E18.5.
We have previously shown that laser-capture microdissection followed by RT-PCR is a sensitive method for testing the level of cre-mediated recombination of conditional alleles (Yang et al., 2008) . Here, we used this approach to examine the EGL from E18.5 embryos of the genotypes RBP-J lox/lox ;GFAP-Cre and RBP-J lox/lox controls. The RBP-J conditional allele used here has been used in many studies and, through excision of exons 6 and 7, leads to an abrogation of canonical Notch signaling (Yamamoto et al., 2003) . We chose the EGL because medulloblastoma originate from this cell layer and since the cells comprising it are derived from the GFAP þ cells of the VZ, a high level of RBP-J gene excision in the VZ would be reflected in the EGL. cDNA from isolated RNA was used as template for a PCR with primers flanking the deleted region of the RBP-J gene and results confirm a high efficiency of RBP-J gene excision in all mutants tested (Figures 1a and b) . In situ hybridization of RBP-J lox/lox ;GFAP-Cre E18.5 cerebellum confirmed loss of RBP-J expression from the EGL (Figure 1c) .
Loss of Notch signaling in GFAP
þ cells of the cerebellum promotes a developmental delay and asymmetric stem cell division but is rescued by cell autonomous Hedgehog pathway activation Next, we addressed the consequences of ablation of Notch signaling and the activation of the Hedgehog pathway from E12. ;GFAP-Cre embryos at E18.5 the proliferative phenotype of the Ptc1 inactivation appears to be diminished ( Figure 2d ) suggesting that loss of RBP-J may be acting to restrain GNP development when cell autonomous Hedgehog pathway activation is present.
To investigate the developmental consequences of Notch ablation and Hedgehog activation in more detail we next examined the expression of bIII-tubulin, a marker for granule neurons that have committed to the lineage but are not yet fully mature (Kempermann et al., 2003) . Compared with control E18.5 cerebellum (Figure 2e ), the EGL from Ptc1 lox/lox ;GFAP-Cre mice not only shows an expanded pool of GNPs but also strong bIII-tubulin staining. This observation is consistent with our previous data that indicated that despite the mitogenic Hedgehog signal, a significant proportion of GNPs can exit the cell cycle and begin to differentiate into granule neurons (Yang et al., 2008) . Figure 2f Figure S1 ). Further investigation of the expression of Notch and Hedgehog pathway targets revealed that expression of the canonical Notchsignaling target gene Hes5 is lost from the EGL at E18.5 in the absence of RBP-J as expected (Figures 3a and c) and is not restored after Hedgehog pathway activation (Figure 3d ). The Hes1 gene is a context-dependent target gene of both the Notch and Hedgehog-signaling pathways (Ingram et al., 2008; Wall and Wallace, 2009) and is expressed at a low level in the E18.5 EGL of both control and RBP-J lox/lox ;GFAP-Cre mice (Figures 3e  and g ), but is significantly upregulated after Hedgehog pathway activation in both Ptc1 lox/lox ;GFAP-Cre and Ptc1 lox/lox ;RBP-J lox/lox ;GFAP-Cre mice (Figures 3f and h ). ;RBP-J lox/lox ;GFAP-Cre EGL (m-p). All pictures per panel were taken at the same magnification, scale bars represent 200 mm for hematoxylin and eosin, 50 mm for bIII-tubulin staining and 50 mm for in situ hybridization images. Nuclei in fluorescent images were counterstained with DAPI.
We have previously defined that Hedgehog signaling can regulate stem cell numbers early in cerebellar development, and we and others have previously noted that medulloblastoma can be initiated in the stem like cells of the VZ (Schuller et al., 2008; Yang et al., 2008) . Accordingly, we next examined the interaction between Notch and Hedgehog signaling in the development of the proliferative compartment of the cerebellum. Sox2 marks stem cells of the VZ and also Bergmann glia in the developing cortex of the cerebellum (Sottile et al., 2006 and Figure 4a) . The VZ of Ptc1 lox/lox ;GFAP-Cre mice shows a slight expansion and the Rhombic lip (RL) and EGL have increased numbers of Sox2 þ cells compared with wild-type (Figures 4a and b) consistent with an increase in stem cells, whereas in the absence of Notch signaling stem cell numbers are reduced (Figure 4c ). It is interesting to note that cell autonomous Hedgehog pathway activation in the VZ and EGL appears to promote a stem cell fate even in the absence of Notch signaling (Figure 4d ). We then analyzed the cerebellar proliferative compartment using a primary neurosphere assay as we have described previously (Yang et al., 2008) . In this assay, the pool of total stem and progenitor cells can be enumerated following plating at clonal density but it does not distinguish between the two populations. Analysis of RBP-J lox/lox ; GFAP-Cre cerebellum at E18.5 indicates that in the absence of Notch signaling these mutants have a significant increase in sphere numbers compared with controls ( Figure 4e ). As the loss of Notch signaling is thought to promote differentiation the increase in sphere numbers likely reflects an increased promotion of stem cell to progenitor cell division in combination with the possible developmental delay indicated above (Figures 2   and 3 ). We next examined this possibility by continuous culture of neurospheres from all genotypes and measuring the rate of clonal expansion. Under these conditions the slope of the line reflects the frequency of symmetric division such that a lower slope indicates an increasing probability of a stem cell diving to form a stem and a progenitor cell (asymmetry) (Galli et al., 2002) as opposed to symmetric division into two daughter stem cells and it is clear that loss of Notch signaling in the VZ results in a significant bias towards asymmetric division (Figure 4f) . In contrast to the in vivo and ex vivo data (Figures 4a-e) , the loss of Ptc1 had no effect on the growth of neurospheres in long-term cultures (Figure 4f ), reflecting the loss of overall Hedgehog pathway responsiveness upon long-term culture irrespective of genotype (data not shown)-a phenomenon which has been shown previously but remains unexplained (Sasai et al., 2006) .
Overall, these data indicate that while loss of Notch signaling from the VZ/EGL promotes some modest effects on stem cells and a possible developmental delay at E18.5, cerebellar development remains largely intact. In addition, a population of Hedgehog-activated GNPs persists in the EGL of the Ptc1 lox/lox ;RBP-J lox/lox ;GFAPCre cerebellum, which have the appearance of early medulloblastoma formation, as defined previously in Ptc1 lox/lox ;GFAP-Cre mice (Yang et al., 2008) .
Loss of Notch signaling does not block medulloblastoma formation initiated by Ptc1 deletion
We have shown that medulloblastoma form in 100% of Ptc1 lox/lox ;GFAP-Cre mice by p21, and that these tumors can be propagated through orthotopic (Yang et al., 2008) or subcutaneous transplantation into immunocompromised mice (data not shown, and Figure 5 ) with equal efficiency and fidelity. As the homozygous loss of the RBP-J allele under the control of GFAP-Cre results in perinatal lethality likely due to severe neocortical defects we adopted a transplantation approach using cells purified from the E18.5 cerebellum to investigate whether Notch inhibition can block the formation and growth of Hedgehog-induced medulloblastoma. When injecting a population of 1 Â 10 6 cells, neither cells from controls nor those from RBP-J lox/lox ;GFAP-Cre embryos led to tumor formation. However, cells from Ptc1 lox/lox ; GFAP-Cre as well as those from Ptc1 lox/lox ;RBP-J lox/lox ; GFAP-Cre cerebella gave rise to tumors within 5-8 weeks post injection (Figure 5a ). Tumors from both genotypes display similar phenotypes with small round granular cells comparable with GNPs interspersed with blood vessels (Figure 5c ) and expressed Math1 and Gli1, consistent with our previous data characterizing murine medulloblastoma (Figure 5c and, (Yang et al., 2008) ). As previously noted, medulloblastoma generated by orthotopic injection of 1 Â 10 6 cells will develop tumors by p21 (Yang et al., 2008) and we cannot completely exclude the possibility that survival of mice with intra-cranial tumors rather than subcutaneous transplants might be improved in the absence of Notch signaling. Nonetheless, in our transplant system, tumors initiated and grew in the absence of RBP-J.
To address the possibility that tumors from Ptc1 lox/lox ; RBP-J lox/lox ;GFAP-Cre EGL were derived from cells with incomplete inactivation of RBP-J we confirmed deletion of the Ptc1 and RBP-J alleles by testing floxing levels of RNA isolated from tumors. All tumors show a high level of loss of both Ptc1 and RBP-J (Figure 5b ) confirming that they are unlikely to result from an RBP-J þ cell population and are truly null for canonical Notch signaling. In addition, real-time quantitative RT-PCR confirmed loss of expression of the Notch target Hes5 in these tumors (data not shown). ;GFAP-Cre neurospheres we show a significant reduction in stem cells compared with controls (slope: 0.83 þ /À 0.0202, P-value o0.0001 and slope: 0.7773 þ /À 0.04409, P-value compared to control o0.0001, respectively).
Discussion
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2004; Yokota et al., 2004; Dakubo et al., 2006) . Notch signaling is well recognized to influence neuronal and glial differentiation in the cerebellum. For example, loss of the ligand Jag1 or the Notch1 receptor from E8.5 in neuroepithelial cells leads to premature differentiation of GNPs and migration defects , (Weller et al., 2006) and formation of Bergmann glial cells is regulated by RBP-J (Komine et al., 2007) . Conversely, activation of the Notch2 receptor in cultured granule neuron precursors acts as a mitogenic signal and inhibits their differentiation (Solecki et al., 2001) . Previously, we have shown that the loss of Ptc1 under the control of GFAP-Cre leads to medulloblastoma following lineage restriction of the Hedgehogactivated GNPs (Yang et al., 2008) and here we tested the hypothesis that Notch signaling has a key role in medulloblastoma development.
Unlike Ptc1 lox/lox ;GFAP-Cre mice, RBP-J lox/lox ;GFAPCre mice show perinatal lethality and this is not rescued in Ptc1 lox/lox ;RBP-J lox/lox ;GFAP-Cre animals. In addition to the relatively subtle cerebellar phenotype we describe here, RBP-J lox/lox ;GFAP-Cre and Ptc1 lox/lox ; RBP-J lox/lox ;GFAP-Cre animals have a severe neocortical defect such that the patterning of this tissue is perturbed and there are vascular defects, which lead to substantial bleeding into the dorsal brain in the perinatal period. Accordingly, we were unable to follow the development of medulloblastoma in vivo through to p21 and beyond when using the RBP-J lox allele in combination with GFAP-Cre. However, we have previously shown that medulloblastoma initiated late in embryogenesis can be subsequently transplanted into immunocompromised mice to give rise to tumors. Consequently, in this study we used a transplant approach to overcome the perinatal lethality of inactivating the RBP-J alleles. The advantage of using the GFAP-Cre allele in these experiments is that it is active in the ventricular zone and enables the consequences of manipulating both the Hedgehog and Notch pathways on the stem cell niche to be examined.
The Notch pathway has been implicated in controlling the balance between symmetric and asymmetric stem cell division in a number of tissues (Louvi and Artavanis-Tsakonas, 2006) . We considered that one of the possible consequences of loss of Notch signaling by deletion of RBP-J under the control of GFAP-Cre could be substantial cerebellar defects, including a significant diminution of the GNP pool from which medulloblastoma arise. We observed a reduced staining with bIIItubulin, Math1 and Gli1 suggesting that loss of RBP-J in the ventricular zone was inducing a developmental delay. However, activation of the Hedgehog pathway was sufficient to reverse this phenomenon and the E18.5 EGL of Ptc1 lox/lox ;RBP-J lox/lox ;GFAP-Cre mice contained a substantial population of mitotically active Math1 þ granule neuron precursors with the potential to become medulloblastoma. The molecular basis of this interaction of the two pathways is not known but the long-term consequences of the Hedgehog/Notch interaction in cerebellar development could be studied in future using the models we have developed here in association with other Cre alleles such as Math1.
We have previously shown that the Hedgehog pathway can act to regulate the proliferative compartment of the cerebellum (Yang et al., 2008) and the pathway also appears to have a role in controlling stem cell numbers in dorsal brain and other organs such as skin (Adolphe et al., 2004) . Similarly, the Notch pathway is important in controlling stem cell numbers in a number of organ systems including the CNS and the experiments described here enabled us to examine the interaction between Notch and Hedgehog at E18.5 in the cerebellum. On the basis of Sox2 staining, a marker for neuronal stem cells, we noted that ablation of RBP-J promoted loss of stem cells but activation of Hedgehog signaling could promote a stem cell fate, even in the absence of Notch signaling. Analysis of the proliferative compartment using a neurosphere assay showed an increase in sphere numbers in the absence of RBP-J compared with both wild type and Hedgehog-activated cells but this was corrected in cells derived from Ptc1 lox/lox ;RBP-J lox/lox ;GFAP-Cre mice. The neurosphere assay enables the enumeration of stem and progenitor cells but cannot differentiate between them. The increase in colony number we observed with the loss of RBP-J likely occurs since there is not only a shifted balance between stem and progenitors but also an associated developmental delay that results in a reduced rate of exit from the stem/progenitor cell niche and therefore there is an expansion in the number of 'colony forming cells'. In the E18.5 cerebellum from Ptc1 lox/lox ;RBP-J lox/lox ; GFAP-Cre mice the number of spheres is decreased to control levels (Figure 4e ) suggesting that Hedgehog pathway activation was sufficient to restore the balance between stem and progenitor cells and ameliorate the developmental delay, as indicated by the Sox2 expression data. This interpretation of the data is consistent with the conclusions of Gao et al. (2009) , who noted that loss of RBP-J under the control of Nestin-Cre in the stem cell niche of the developing dorsal forebrain promoted early differentiation of stem cells to progenitors ('intermediate neural progenitors ', inps) , and this then led to an increase in the number of colonies in a neurosphere assay. Although the activation of the Hedgehog pathway appears to have promoted the appearance of some Sox2 þ staining in the EGL, we observed no overall increase in the number of neurospheres compared with controls, indicating that although the balance between stem and progenitors could have shifted, there was no overall change in the total number of stem and progenitors. It is interesting to note that when Gao et al. (2009) performed analyses on dorsal brain at late neurogenic stages such as E17.5 rather than E11.5, loss of RBP-J led to a large decrease in neurospheres, consistent with the notion that early promotion of the progenitor compartment results in a premature exhaustion of stem cells at later time points. On that basis, one would predict that the stem cells of the cerebellum would behave in a similar fashion in RBP-J null mice at later time points such as p7, which is one of the latest stages in wild-type mice where cerebellar neurospheres can be generated. Owing to the lethality of the RBP-J lox/lox ;GFAP-Cre model, such an RBP-J is not required for Hedgehog-induced medulloblastoma E Julian et al investigation would likely require an inducible cre approach in future studies. Nonetheless, our combined immunohistochemistry and neurosphere data indicate that despite some dysregulation of both the stem cell compartment and neurogenesis from loss of Notch signaling, cerebellar development does not appear to be fundamentally disrupted at E18.5, and activation of the Hedgehog pathway can largely overcome this phenotype, leading to a cerebellum with a substantial pool of cycling GNPs. Although the mechanism of the interaction between Notch and Hedgehog signaling is not clear, it is interesting to speculate there may be some ultimate therapeutic benefit in activating Hedgehog signaling in neuronal stem cells as we have shown in this study that activating the pathway can overcome a strong differentiating signal such as loss of Notch signaling. The data presented here indicate that even in the absence of canonical Notch signaling, Hedgehog-driven medulloblastoma will still initiate and develop. At E18.5 we did observe a diminution in the number of Math1 Although Hedgehog pathway components appear to be mutated in a minority of medulloblastoma, the potential interaction with other genetic pathways such as Wnt signaling (Saran, 2009 ) make it possible that Hedgehog signaling is having a wider role in the development of the tumor without itself being mutated and significant Hedgehog pathway activation can be detected in the majority of medulloblastoma (Hallahan et al., 2004) , particularly using sensitive RT-PCR-based methods rather than microarrays. On the basis of the experiments reported here, we suggest that in any clinical trial of Notch pathway inhibitors for the treatment of medulloblastoma it will be of paramount importance to determine the genetic signature of the tumor, particularly around the Hedgehog pathway.
A recent report notes that targeting Hes1 function may reduce medulloblastoma growth (Garzia et al., 2009) . Rather than regard this as an indication of Notch pathway modulation, it is worth noting that we and others have described that Hes1 can also be a Notchindependent transcriptional target of the Hedgehog pathway (Solecki et al., 2001; Ingram et al., 2008; . The results from this study support this conclusion (Figure 3 ) because it is clear that Hes5 expression is lost in RBP-J null tissue during cerebellar development at E18.5 but Hes1 is not. In Hedgehog pathway-activated cells Hes1 is significantly upregulated and Hes5 is not. As this observation extends to medulloblastoma generated from Ptc1 lox/lox ;RBP-J lox/lox ; GFAP-Cre mice (data not shown) future studies looking more specifically at the role of Hes1 in medulloblastoma would be warranted, although they may be complicated by the functional redundancy between Hes family members and others such as Hey1 (Imayoshi et al., 2008) .
Materials and methods
Mouse models
All work involving mice was performed with approval and according to guidelines of the University of Queensland Animal Ethics Committee. Mouse models used were Ptc1 conditional mice (Ellis et al., 2003) and RBP-J conditional mice (Tanigaki et al., 2002) crossed with the GFAP-Cre line (Zhuo et al., 2001) . SCID mice were used as tumor transplant recipients. All staining analyses was performed on 3-5 individuals per genotype and representative images for each genotype were included in Figures.
Laser capture microdissection
Fresh frozen tissue in OCT compound (Tissue Tek by Sakura Finetek Co., Tokyo, Japan) was sectioned (10 mm) onto PENmembrane slides (PALM, Bernried, Germany) and stained with cresyl violet (Ambion/Applied Biosystems, Austin, TX, USA). Dissection was performed using a Zeiss Axiovert 200 Inverted microscope (Carl Zeiss Pty Ltd, North Ryde, NSW, Australia) and the PALM Robomover software. RNA was extracted from captured tissue using the RNeasy Micro kit (Qiagen, Hilden, Germany). Reverse transcription was performed using the Superscript III system by Invitrogen (Carlsbad, CA, USA). The following primers were used for PCR detection of the floxed allele : forward 5 0 -CATCTCCAAAC CCTCCAAAA-3 0 , reverse 5 0 -GTCCAGGAAGCTCCATCGT-3 0 .
Immunofluorescence
Brain samples were fixed in 4% paraformaldehyde over night and either embedded in paraffin or cryoprotected in 30% sucrose before embedding in OCT compound. In situ hybridization In situ hybridization was performed as previously published (Adolphe et al., 2006) . In summary, probes were prepared using DIG-labeled probe amplification followed by phenol/ chloroform extraction and precipitation. 6 mm paraffin-embedded sections were treated with 2 mg/ml ProK (Roche Diagnostics, Mannheim, Germany) in TE buffer, fixed in 4% paraformaldehyde and acetylated. Hybridization was performed in hybridization buffer at 64 1C for Gli1 and 65 1C for Math1, Hes5 and RBP-J overnight. A series of SSC washes was followed by blocking and washing (DIG block and wash buffer set, Roche) before incubation with anti-DIG-AP antibody (Roche). Color reaction was performed using 3.5 mg/ml nitroblue tetrazolium (NBT) and 1.75 mg/ml 5-Bromo-4-chloro-3-indolyl-phosphate (BCIP) (both Roche) in 10% Polyvinylalcohol (PVA) (Sigma). Color formation was stopped in TE solution followed by counter staining with nuclear fast red (Vector Labs), post-fixation and mounting. Probes used were Math1 (a gift from J Johnson, Dallas, TX, USA), Gli1 (a gift from A Joyner, New York, NY, USA), RBP-J (a gift from T Honjo, Kyoto, Japan) and Hes5 (a gift from R Kageyama).
Microscopy
Light and general fluorescence microscopy was performed using an Olympus BX-51 upright microscope. Confocal images were taken on a Zeiss LSM 510 META.
Quantification of immunofluorescence and in situ hybridization data To quantitate immunofluorescence staining for bIII-tubulin the number of bIII-tubulin-expressing cells relative to the number of cells (by DAPI staining) was counted in three fields adjacent to the EGL per individual and three individuals were quantitated per genotype. For in situ hybridization for Math1 and Gli1 three fields within the EGL were quantitated per individual, with three individuals per genotype. The total cell number per field was determined via nuclear fast red counterstain. Statistical analysis was performed using unpaired t-test on the nine values per genotype in Graphpad Prism 4.
Stem/progenitor cell analysis E18.5 cerebellum cells were harvested and subsequently dissociated. Cells were plated at a density of 1 Â 10 5 cells per ml in 200 ml NSA media (Neurosphere media containing 10% Neurocult neural stem cell proliferation supplement (Stem Cell Technologies, Tullamarine, VIC, Australia), 5% BSA (Sigma), 1% Penicillin/Streptomycin) containing EGF (20ng/ml) in a 96-well plate. For each individual the assay was set up in triplicates. The number of spheres per well was counted 5 days after plating. Statistical analysis was performed using Graphpad Prism 4 for unpaired t-tests.
For passaging cells/neurospheres were harvested and dissociated in 0.05% trypsin (Gibco by Invitrogen) followed by addition of trypsin inhibitor. Resuspended cell pellets were then replated at a density of 0.5 Â 10 5 cells per ml. Cell counts at every passage were used for growth curve analysis. For analysis of neurosphere-replating assays in Graphpad Prism 4 expansion numbers were transformed into LOG and linear regression analysis was performed on resulting curves. Student's t-test analysis was used to determine significant differences between slopes.
Subcutaneous injection of cell suspensions into SCID mice 1 Â 10 6 cells were injected in a total volume of 200 ml in Dulbecco's phosphate-buffered saline (Invitrogen) subcutaneously into the flanks of SCID mice. Isoflurane was used as anaesthetic. Tumors were collected when a cross sectional diameter of approximately 1 cm was reached.
